{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T13:30:48Z","timestamp":1792416648483,"version":"4.4.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1136\/ijgc-2019-001134","type":"journal-article","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T05:56:02Z","timestamp":1587534962000},"page":"749-756","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Quality of life of locally advanced cervical cancer patients after neoadjuvant chemotherapy followed by chemoradiation versus chemoradiation alone (CIRCE trial): a randomized phase II trial"],"prefix":"10.1016","volume":"30","author":[{"given":"Fernanda","family":"Nunes de Arruda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"da Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Bonadio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abra\u00e3o","family":"Dornellas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geertruida H","family":"de Bock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3176-9747","authenticated-orcid":false,"given":"Maria","family":"Del Pilar Estevez Diz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2019-001134_bb0010","unstructured":"INCA . Available: http:\/\/www.inca.gov.br [Accessed assessed in October 2018]."},{"key":"10.1136\/ijgc-2019-001134_bb0015","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1136\/ijgc-2019-001134_bb0020","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/CCO.0000000000000471","article-title":"The management of locally advanced cervical cancer","volume":"30","author":"Naga Ch","year":"2018","journal-title":"Curr Opin Oncol"},{"key":"10.1136\/ijgc-2019-001134_bb0025","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1056\/NEJM199904153401501","article-title":"Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer","volume":"340","author":"Morris","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2019-001134_bb0030","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1056\/NEJM199904153401503","article-title":"Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage Ib cervical carcinoma","volume":"340","author":"Keys","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2019-001134_bb0035","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1200\/JCO.2000.18.8.1606","article-title":"Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix","volume":"18","author":"Peters","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2019-001134_bb0040","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.1999.17.5.1339","article-title":"Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study","volume":"17","author":"Whitney","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2019-001134_bb0045","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1056\/NEJM199904153401502","article-title":"Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer","volume":"340","author":"Rose","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2019-001134_bb0050","doi-asserted-by":"crossref","first-page":"5802","DOI":"10.1200\/JCO.2008.16.4368","article-title":"Chemoradiotherapy for cervical cancer meta-analysis collaboration reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials","volume":"26","author":"Vale","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2019-001134_bb0055","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1200\/JCO.2009.25.9663","article-title":"Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIb to IVA carcinoma of the cervix","volume":"29","author":"Due\u00f1as-Gonz\u00e1lez","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2019-001134_bb0060","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1023\/A:1011117617514","article-title":"A phase II study of gemcitabine and cisplatin combination as induction chemotherapy for untreated locally advanced cervical carcinoma","volume":"12","author":"Due\u00f1as-Gonzalez","year":"2001","journal-title":"Ann Oncol"},{"key":"10.1136\/ijgc-2019-001134_bb0065","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ygyno.2005.01.048","article-title":"Neoadjuvant gemcitabine and cisplatin followed by radical surgery in (bulky) squamous cell carcinoma of cervix stage IB2","volume":"97","author":"Termrungruanglert","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2019-001134_bb0070","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/annonc\/mdf196","article-title":"Concomitant chemoradiation versus neoadjuvant chemotherapy in locally advanced cervical carcinoma: results from two consecutive phase II studies","volume":"13","author":"Duenas-Gonzalez","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1136\/ijgc-2019-001134_bb0075","first-page":"521","article-title":"Synergistic interaction between cisplatin and gemcitabine in vitro","volume":"2","author":"Bergman","year":"1996","journal-title":"Clin Cancer Res"},{"key":"10.1136\/ijgc-2019-001134_bb0080","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1200\/JCO.19.00674","article-title":"Neoadjuvant chemotherapy with cisplatin and gemcitabine followed by chemoradiation versus chemoradiation for locally advanced cervical cancer: a randomized phase II trial","volume":"37","author":"da Costa","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2019-001134_bb0085","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/IGC.0000000000000207","article-title":"A systematic review of quality of life and sexual function of patients with cervical cancer after treatment","volume":"24","author":"Ye","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2019-001134_bb0090","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.ygyno.2017.07.006","article-title":"Phase II trial of neoadjuvant chemotherapy followed by chemoradiation in locally advanced cervical cancer","volume":"146","author":"de Azevedo","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2019-001134_bb0095","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1038\/bjc.2013.230","article-title":"A phase II study of weekly neoadjuvant chemotherapy followed by radical chemoradiation for locally advanced cervical cancer","volume":"108","author":"McCormack","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1136\/ijgc-2019-001134_bb0100","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organisation for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1136\/ijgc-2019-001134_bb0105","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1002\/cncr.22217","article-title":"The European Organization for Research and Treatment of Cancer (EORTC) quality-of-life questionnaire cervical cancer module: EORTC QLQ-CX24","volume":"107","author":"Greimel","year":"2006","journal-title":"Cancer"},{"key":"10.1136\/ijgc-2019-001134_bb0110","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jclinepi.2015.08.007","article-title":"Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ-C30 is robust","volume":"69","author":"Giesinger","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"10.1136\/ijgc-2019-001134_bb0115","unstructured":"EORTC Quality of Life Group website . Available: http:\/\/qol.eortc.org\/manuals\/ [Accessed Oct 2018]."},{"key":"10.1136\/ijgc-2019-001134_bb0120","author":"Fayers","year":"2001"},{"key":"10.1136\/ijgc-2019-001134_bb0125","author":"Fregnani","year":"2013","journal-title":"Propriedades psicom\u00e9tricas de dois instrumentos para avalia\u00e7\u00e3o dA qualidade de vida relacionada sa\u00fade em mulheres com c\u00e2ncer de COLO de \u00fatero. Ribeir\u00e3o Preto: Escola de Enfermagem de Ribeir\u00e3o Preto"},{"key":"10.1136\/ijgc-2019-001134_bb0130","first-page":"2151","article-title":"Further evaluation of the EORTC QLQ-C30 psychometric properties in a large Brazilian cancer patient cohort as a function of their educational status","volume":"12","author":"Paiva","year":"2014","journal-title":"Support Care Cancer"},{"key":"10.1136\/ijgc-2019-001134_bb0135","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1200\/JCO.1998.16.1.139","article-title":"Interpreting the significance of changes in health-related quality-of-life scores","volume":"16","author":"Osoba","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2019-001134_bb0140","first-page":"3095","article-title":"Quality of life of patients with advanced cervical cancer before and after chemoradiotherapy","volume":"17","author":"Dahiya","year":"2016","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1136\/ijgc-2019-001134_bb0145","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ygyno.2011.09.041","article-title":"Quality of life and emotional distress in early stage and locally advanced cervical cancer patients: a prospective, longitudinal study","volume":"124","author":"Ferrandina","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2019-001134_bb0150","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/1747-0080.12414","article-title":"Influence of chemoradiotherapy on nutritional status, functional capacity, quality of life and toxicity of treatment for patients with cervical cancer","volume":"75","author":"Aredes","year":"2018","journal-title":"Nutr Diet"},{"key":"10.1136\/ijgc-2019-001134_bb0155","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.ijrobp.2008.06.1905","article-title":"Health-related quality of life in cervical cancer survivors: a population-based survey","volume":"73","author":"Korfage","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2019-001134_bb0160","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0090-8258(87)90270-8","article-title":"Hormonal replacement therapy in patients after cervical cancer treatment","volume":"26","author":"Ploch","year":"1987","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2019-001134_bb0165","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.maturitas.2009.11.017","article-title":"Hormone replacement after gynaecological cancer","volume":"65","author":"Singh","year":"2010","journal-title":"Maturitas"},{"key":"10.1136\/ijgc-2019-001134_bb0170","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJM199905063401802","article-title":"Vaginal changes and sexuality in women with a history of cervical cancer","volume":"340","author":"Bergmark","year":"1999","journal-title":"N Engl J Med"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24001439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24001439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2019-001134","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:25:37Z","timestamp":1753233937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24001439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S1048891X24001439"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2019-001134","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality of life of locally advanced cervical cancer patients after neoadjuvant chemotherapy followed by chemoradiation versus chemoradiation alone (CIRCE trial): a randomized phase II trial","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2019-001134","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, an indication of whether changes were made, and the use is non-commercial. See: http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/.","name":"copyright","label":"Copyright"}]}}